RS142042446 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (16)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Apolipoprotein B levels | GTAA | OR: 0.25 | 6E-1110 | PubMed |
| Low density lipoprotein cholesterol levels | GTAA | OR: 0.21 | 2E-738 | PubMed |
| C-reactive protein levels | GTAA | OR: 0.21 | 4E-738 | PubMed |
| Total cholesterol levels | GTAA | OR: 0.18 | 8E-560 | PubMed |
| Alzheimer's disease or family history of Alzheimer's disease | GTAA | — | 9E-202 | PubMed |
| Alzheimer's disease | GTAA | — | 2E-136 | PubMed |
| Apolipoprotein A1 levels | GTAA | β: 0.087 | 8E-120 | PubMed |
| High density lipoprotein cholesterol levels | GTAA | β: 0.062 | 1E-62 | PubMed |
| Aspartate aminotransferase to alanine aminotransferase ratio | GTAA | β: 0.048 | 1E-40 | PubMed |
| Triglyceride levels | GTAA | β: 0.045 | 2E-37 | PubMed |
| Alanine aminotransferase levels | GTAA | β: 0.037 | 1E-25 | PubMed |
| Cystatin C levels | GTAA | β: 0.03 | 8E-17 | PubMed |
| Creatinine levels | GTAA | β: 0.029 | 1E-16 | PubMed |
| Estimated glomerular filtration rate | GTAA | β: 0.029 | 1E-16 | PubMed |
| Serum alkaline phosphatase levels | GTAA | β: 0.029 | 1E-15 | PubMed |
| Direct bilirubin levels | GTAA | β: 0.023 | 2E-9 | PubMed |